Loading clinical trials...
Loading clinical trials...
Study of COVID-19 seroprevalence in precarious population living in shelters of Samusocial de Paris and in staff working in these centers during COVID-19 epidemic.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborators
NCT05115617 · SARS-CoV2 Infection, Covid19, and more
NCT04903132 · SARS-CoV2 Infection
NCT06181292 · SARS-CoV2 Infection
NCT06247059 · SARS-CoV2 Infection, Influenza Viral Infections, and more
NCT06085547 · SARS-CoV2 Infection
Haltes pour femmes
Paris
LHSS Saint-Michel
Paris
LHSS Ridder-Plaisance
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions